ING Groep »

Nektar Therapeutics shares owned by ING Groep

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by ING Groep from 13F filings

Historical chart of ING Groep investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by ING Groep consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by ING Groep

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.2M 100k 42.28

More positions owned by ING Groep

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Bank of America Corporation (BAC)
Linde SHS (LIN)
Honeywell International (HON)
Select Sector Spdr Tr State Street Ind (XLI)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Eli Lilly & Co. (LLY)
salesforce (CRM)

View all positions for ING Groep

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics